March 20, 2020 10:01 AM EDTUpdated March 25, 06:21 AM
Financing
Startups

A key play­er be­hind 2 multi­bil­lion-dol­lar biotech M&A deals is back in the start­up busi­ness

John Carroll

Editor & Founder

Pratik Shah and Aseem Ansari have snared a $45 mil­lion launch round for De­sign Ther­a­peu­tics, a San Diego-based out­fit that is fo­cused on de­gen­er­a­tive dis­eases …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

A service from the Financial Times